Thomas X - Search Results

1

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.

Tavernier E, Boiron JM, Huguet F, Bradstock K, Vey N, Kovacsovics T, Delannoy A, Fegueux N, Fenaux P, Stamatoullas A, Tournilhac O, Buzyn A, Reman O, Charrin C, Boucheix C, Gabert J, Lhéritier V, Vernant JP, Dombret H, Thomas X; GET-LALA Group; Swiss Group for Clinical Cancer Research SAKK; Australasian Leukaemia and Lymphoma Group. Tavernier E, et al. Among authors: thomas x. Leukemia. 2007 Sep;21(9):1907-14. doi: 10.1038/sj.leu.2404824. Epub 2007 Jul 5. Leukemia. 2007. PMID: 17611565 Clinical Trial.

2

Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.

Archimbaud E, Thomas X, Campos L, Magaud JP, Doré JF, Fiere D. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1992 Apr;6(4):265-71. Leukemia. 1992. PMID: 1375302

3

Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderly.

Archimbaud E, Anglaret B, Thomas X, Devaux Y, Ffrench M, Sebban C, Troncy J, Fiere D. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1992 Aug;6(8):776-9. Leukemia. 1992. PMID: 1640728

4

High risk myelodysplastic syndrome coexistent with chronic lymphocytic leukemia for more than 9 years: inhibition of the myeloid clone by the lymphoid clone?

Bastion Y, Thomas X, Felman P, Campos L, Charrin C, Coiffier B. Bastion Y, et al. Among authors: thomas x. Leukemia. 1991 Nov;5(11):1006-9. Leukemia. 1991. PMID: 1961029

5

Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells.

Archimbaud E, Thomas X, Campos L, Magaud JP, Fiere D, Doré JF. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1991 Nov;5(11):967-71. Leukemia. 1991. PMID: 1961038

6

Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns.

Guyotat D, Campos L, Thomas X, Vila L, Shi ZH, Charrin C, Gentilhomme O, Fiere D. Guyotat D, et al. Among authors: thomas x. Am J Hematol. 1990 May;34(1):26-31. doi: 10.1002/ajh.2830340107. Am J Hematol. 1990. PMID: 2327401

7

CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.

Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. Thomas X, et al. Leukemia. 1995 Feb;9(2):249-53. Leukemia. 1995. PMID: 7532767

8

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.

Archimbaud E, Thomas X, Leblond V, Michallet M, Fenaux P, Cordonnier C, Dreyfus F, Troussard X, Jaubert J, Travade P, et al. Archimbaud E, et al. Among authors: thomas x. J Clin Oncol. 1995 Jan;13(1):11-8. doi: 10.1200/JCO.1995.13.1.11. J Clin Oncol. 1995. PMID: 7799010

9

Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.

Thomas X, Danaïla C, Bach QK, Dufour P, Christian B, Corront B, Bosly A, Bastion Y, Gratecos N, Leblay R, et al. Thomas X, et al. Ann Hematol. 1995 Feb;70(2):65-9. doi: 10.1007/BF01834381. Ann Hematol. 1995. PMID: 7880925 Clinical Trial.

10

Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia.

Archimbaud E, Thomas X, Michallet M, Jaubert J, Troncy J, Guyotat D, Fiere D. Archimbaud E, et al. Among authors: thomas x. J Clin Oncol. 1994 Feb;12(2):262-7. doi: 10.1200/JCO.1994.12.2.262. J Clin Oncol. 1994. PMID: 8113835 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters